
Wang, Ying
Changping Technology Innodevelop Group (CTID) , China
Ying Wang is General Manager of Beijing Changping Technology Innodevelop Group (CTID) and chairwoman of Beijing Zhongguancun Life Science Park Development Co., Ltd.
CTID is dedicated to equity investment and innovation incubation in the fields of future health, future information, future energy, and future manufacturing. We operate and manage several industrial parks, such as Zhongguancun Life Science Park, International Precision Medicine Industrial Park at the Champion Bio Life Science Valley, International Medical Equipment City, Xinyuan Science and Technology Park, and Huitian Inno Community, as well as multiple industrial service platforms. They have invested in over 50 first-tier investment institutions through the mother funds under our management, and directly invested in more than 40 enterprises through our direct investment funds. Some of our representative investment cases include Eyebright (SH.688050), InnoCare (HK.09969), BeiGene (SH.688235), Giant Biogene (HK.02367), TowardPi, Pyrotech, E-Plus-3D, AK Optics, Makesense Energy, Mingyang Hydrogen Energy, among others.
Speaking in
IASP 2025
Breakout 1: Role of innovation spaces in the development of technology, industry, and finance